Kiniksa Pharmaceuticals International (KNSA) Return on Equity [ROE] (2018 - 2026)
Kiniksa Pharmaceuticals International's Return on Equity [ROE] came in at 12.80% for Q2 2026, up 11.80 percentage points from 1.01% a year earlier and up 0.35 percentage points from the prior quarter.
Powered by 
Analysis
Kiniksa Pharmaceuticals International (KNSA) Return on Equity [ROE] (2018 - 2026) Analysis & Trends
For FY2025, Kiniksa Pharmaceuticals International's Return on Equity [ROE] was 11.73%, up 21.58 percentage points from FY2024.
- Return on Equity [ROE] carries a five-year change of +71.79 percentage points (FY2020 to FY2025).
- Going back by year, Return on Equity [ROE] was -9.85% in FY2024 (-13.22 pp), 3.37% in FY2023 (-59.73 pp), 63.10% in FY2022 (+126.65 pp) and -63.55% in FY2021 (-3.49 pp).
- The Q2 2026 figure represents the highest quarterly Return on Equity [ROE] since Q2 2023.
- Year-over-year, Return on Equity [ROE] has increased for five consecutive quarters, with an average year-over-year change of +5.20 percentage points over the last eight quarters.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in Q3 2022 (a gain of 130.97 percentage points), and the weakest in Q2 2024 (a drop of 60.05 percentage points).
- Business Quant data shows KNSA's Return on Equity [ROE] at 12.45% (Q1 2026), 10.70% (Q4 2025) and 6.97% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Kiniksa Pharmaceuticals International | 11.64 Bn | 10.38 Bn | 220.03 Mn | 12.80% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.80% |
| Mar 31, 2026 | 12.45% |
| Dec 31, 2025 | 10.70% |
| Sep 30, 2025 | 6.97% |
| Jun 30, 2025 | 1.01% |
| Mar 31, 2025 | -3.78% |
| Dec 31, 2024 | -9.87% |
| Sep 30, 2024 | -2.08% |
| Jun 30, 2024 | -2.36% |
| Mar 31, 2024 | 1.99% |
| Dec 31, 2023 | 3.34% |
| Sep 30, 2023 | -1.64% |
| Jun 30, 2023 | 57.69% |
| Mar 31, 2023 | 49.93% |
| Dec 31, 2022 | 47.01% |
| Sep 30, 2022 | 53.05% |
| Jun 30, 2022 | -70.10% |
| Mar 31, 2022 | -76.09% |
| Dec 31, 2021 | -79.14% |
| Sep 30, 2021 | -77.92% |
API Access
Kiniksa Pharmaceuticals International Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=KNSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "KNSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=KNSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();